Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19492356 | 0.89 | TGFBR1 (0.59) | TGFBR1MAPK14 | |
| SCHEMBL247975 | 0.86 | TGFBR1 (0.65) | TGFBR1MAPK14 | |
| SCHEMBL248565 | 0.86 | TGFBR1 (0.77) | TGFBR1MAPK14 | |
| SCHEMBL3439281 | 0.84 | TGFBR1 (0.72) | TGFBR1MAPK14 | |
| SCHEMBL249384 | 0.84 | TGFBR1 (0.81) | TGFBR1MAPK14 | |
| SCHEMBL247976 | 0.83 | TGFBR1 (1.00) | TGFBR1MAPK14 | |
| SCHEMBL20603884 | 0.83 | TGFBR1 (0.72) | TGFBR1MAPK14 | |
| SCHEMBL29631969 | 0.83 | TGFBR1 (1.00) | TGFBR1MAPK14 | |
| SCHEMBL248945 | 0.83 | TGFBR1 (1.00) | TGFBR1MAPK14 | |
| SCHEMBL16542420 | 0.82 | TGFBR1 (0.52) | TGFBR1MAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2947081-B1 | 2-Pyridyl substituted imidazoles as therapeutic Alk5 and/or Alk4 inhibitors | EWHA UNIVERSITY-INDUSTRY COLLABORATION FOUND (KR) | 2017-10-18 | — | — | EP | disclosed |
| EP-2947081-A1 | 2-Pyridyl substituted imidazoles as therapeutic Alk5 and/or Alk4 inhibitors | Ewha University-Industry Collaboration Foundation (KR) | 2015-11-25 | — | — | EP | disclosed |
| US-8513222-B2 | Methods of treating fibrosis, cancer and vascular injuries | EWHA University—Industry Collaboration Foundation (KR) | 2013-08-20 | — | — | US | disclosed |
| US-8513222-B2 | Methods of treating fibrosis, cancer and vascular injuries | EWHA University—Industry Collaboration Foundation (KR) | 2013-08-20 | — | — | US | disclosed |
| WO-2012002680-A2 | 2-PYRIDYL SUBSTITUTED IMIDAZOLES AS THERAPEUTIC ALK5 AND/OR ALK4 INHIBITORS | EWHA UNIVERSITY-INDUSTRY COLLABORATION FOUNDATION (KR) | 2012-01-05 | — | — | WO | disclosed |
| US-20110319406-A1 | 2-PYRIDYL SUBSTITUTED IMIDAZOLES AS THERAPEUTIC ALK5 AND/OR ALK4 INHIBITORS | EWHA UNIVERSITY-INDUSTRY COLLABORATION FOUNDATION (KR) | 2011-12-29 | — | — | US | disclosed |
| US-20110319406-A1 | 2-PYRIDYL SUBSTITUTED IMIDAZOLES AS THERAPEUTIC ALK5 AND/OR ALK4 INHIBITORS | EWHA UNIVERSITY-INDUSTRY COLLABORATION FOUNDATION (KR) | 2011-12-29 | — | — | US | disclosed |
| US-20110319408-A1 | Methods of Treating Fibrosis, Cancer and Vascular Injuries | EWHA UNIVERSITY-INDUSTRY COLLABORATION FOUNDATION (KR) | 2011-12-29 | — | — | US | disclosed |
| US-20110319408-A1 | Methods of Treating Fibrosis, Cancer and Vascular Injuries | EWHA UNIVERSITY-INDUSTRY COLLABORATION FOUNDATION (KR) | 2011-12-29 | — | — | US | disclosed |
| US-8080568-B1 | 2-pyridyl substituted imidazoles as therapeutic ALK5 and/or ALK4 inhibitors | EWHA UNIVERSITY - INDUSTRY COLLABORATION FOUNDATION (KR) | 2011-12-20 | — | — | US | disclosed |
| US-8080568-B1 | 2-pyridyl substituted imidazoles as therapeutic ALK5 and/or ALK4 inhibitors | EWHA UNIVERSITY - INDUSTRY COLLABORATION FOUNDATION (KR) | 2011-12-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110319408-A1 | Methods of Treating Fibrosis, Cancer and Vascular Injuries | ACVR1, FLT4, TEK | TGFBR1 8/4885MAPK14 2575/4885 |
| US-20110319406-A1 | 2-PYRIDYL SUBSTITUTED IMIDAZOLES AS THERAPEUTIC ALK5 AND/OR ALK4 INHIBITORS | ALK, ACVR1, ACVRL1 | TGFBR1 4/4885MAPK14 776/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.